日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Blimp-1 integrates alarmin signals in ILC2s and drives proinflammatory functions required for type 2 immunity

Blimp-1整合ILC2细胞中的报警素信号,并驱动2型免疫所需的促炎功能。

Forster, Patrycja M; Preußer, Alexandra; Yano, Hiroshi; Deshpande, Divija; Zhang, Wen; Kowalczyk, Anita; Velleman, Laura; Dubik, Magdalena O; Uddin, Jazib; Emanuel, Elizabeth R; Leclère, Pierre S; Mertens, Richard; Gao, Xuemei; Kofoed-Branzk, Michael; Hauser, Anja E; Mittrücker, Hans-Willi; Diefenbach, Andreas; Artis, David; Klose, Christoph S N

Evaluating the Feasibility of Electronic Patient-Reported Outcomes for a Population Receiving Specific Health Checkups: A Pilot Study

评估电子患者报告结果在接受特定健康检查人群中的可行性:一项试点研究

Yano, Hiroshi; Hosogaya, Naoki; Ide, Shotaro; Kawasaki, Rina; Tadami, Tokuma; Ide, Masatoshi; Murotani, Kenta

Impacts of physical, metabolic, and immunological factors on the exophthalmometry values of a contemporary Japanese population with/without Graves' disease

生理、代谢和免疫因素对当代日本人群(伴/不伴格雷夫斯病)眼球突出度的影响

Nakaji, Erika; Nakamura, Yuta; Horie, Ichiro; Yano, Hiroshi; Nishikido, Shinpei; Nakaji, Keita; Sako, Ayaka; Niri, Tetsuro; Haraguchi, Ai; Akazawa, Satoru; Usa, Toshiro; Oka, Akari; Uematsu, Masafumi; Kawakami, Atsushi

IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer.

IL-33激活的ILC2诱导胰腺癌中的三级淋巴结构

Amisaki Masataka, Zebboudj Abderezak, Yano Hiroshi, Zhang Siqi Linsey, Payne George, Chandra Adrienne Kaya, Yu Rebecca, Guasp Pablo, Sethna Zachary M, Ohmoto Akihiro, Rojas Luis A, Cheng Charlotte, Waters Theresa, Solovyov Alexander, Martis Stephen, Doane Ashley S, Reiche Charlotte, Bruno Emmanuel M, Milighetti Martina, Soares Kevin, Odgerel Zagaa, Moral John Alec, Zhao Julia N, Gönen Mithat, Gardner Rui, Tumanov Alexei V, Khan Abdul G, Vergnolle Olivia, Nyakatura Elisabeth K, Lorenz Ivo C, Baca Manuel, Patterson Erin, Greenbaum Benjamin, Artis David, Merghoub Taha, Balachandran Vinod P

CGRP-related neuropeptide adrenomedullin 2 promotes tissue-protective ILC2 responses and limits intestinal inflammation

CGRP相关神经肽肾上腺髓质素2促进组织保护性ILC2反应并限制肠道炎症

Uddin, Jazib; Yano, Hiroshi; Parkhurst, Christopher N; Zhang, Wen; Ahmed, Anees; Ribeiro de Godoy, Victoria; Wei, Qianru; Panchakshari, Rohit; Henninot, Antoine; Dasgupta, Surya; Gaudino, Stephen; Emanuel, Elizabeth R; Zeng, Peng; Miranda, Isabella; Hu, Elin; Tsou, Amy M; Artis, David

Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD)

伊格列净辅助治疗对 1 型糖尿病肾脏保护作用有限:日本 25 个中心开展的回顾性研究 (IPRA-CKD)

Nakamura, Yuta; Horie, Ichiro; Yano, Hiroshi; Nomoto, Hiroshi; Fukui, Tomoyasu; Yuyama, Yoshihiko; Kawamura, Tomoyuki; Ueda, Mariko; Yamamoto, Akane; Hirota, Yushi; Kusunoki, Yoshiki; Nishida, Kenro; Sekiguchi, Dan; Maeda, Yasutaka; Minami, Masae; Nagayama, Ayako; Iwata, Shimpei; Minagawa, Hitomi; Furukawa, Shinya; Miyake, Teruki; Ueno, Hiroaki; Chinen, Rei; Nakayama, Yoshiro; Masuzaki, Hiroaki; Miyachi, Yasutaka; Okada, Yosuke; Okamoto, Mitsuhiro; Ono, Kaoru; Tanaka, Ken-Ichi; Kurozumi, Akira; Sakai, Takenori; Yamasaki, Hironori; Yasui, Jun-Ichi; Ito, Ayako; Kawakami, Atsushi; Abiru, Norio

Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II): A clinical, ultrasound, and biomarker-based effectiveness after discontinuation and reinitiation of biosimilar infliximab

在 IFX-SIRIUS 研究 I 中,日本类风湿关节炎患者在达到持续临床缓解或低疾病活动度后停用英夫利昔单抗生物类似药(IFX-SIRIUS 研究 II):停用和重新开始使用英夫利昔单抗生物类似药后的临床、超声和生物标志物疗效评估

Shimizu, Toshimasa; Kawashiri, Shin-Ya; Koga, Tomohiro; Kiya, Rieko; Morita, Michiko; Kuroda, Shohei; Tashiro, Shigeki; Morimoto, Shimpei; Yano, Hiroshi; Ueki, Yukitaka; Dobashi, Hiroaki; Nozaki, Yuji; Hosogaya, Naoki; Yamamoto, Hiroshi; Kawakami, Atsushi

A Phase Ib Investigator-Initiated Trial of Filgotinib in Patients With Idiopathic Multicentric Castleman Disease

一项由研究者发起的 Ib 期临床试验,评估 Filgotinib 治疗特发性多中心 Castleman 病患者的疗效

Fukui, Shoichi; Sumiyoshi, Remi; Koga, Tomohiro; Hosogaya, Naoki; Narita, Sawana; Morimoto, Shimpei; Yano, Hiroshi; Katsube, Atsushi; Yano, Shingo; Masaki, Yasufumi; Tsunoda, Shinichiro; Sato, Shuzo; Migita, Kiyoshi; Matsuyama, Kazuko; Kato, Naoki; Kawamoto, Atsuhiko; Kawakami, Atsushi

Dynamics of Serum Cytokines and Chemokines in Patients With Idiopathic Multicentric Castleman Disease: From a Phase Ib Investigator-Initiated Trial of Filgotinib

特发性多中心Castleman病患者血清细胞因子和趋化因子的动态变化:来自一项Filgotinib Ib期研究者发起的试验

Fukui, Shoichi; Sumiyoshi, Remi; Koga, Tomohiro; Hosogaya, Naoki; Narita, Sawana; Morimoto, Shimpei; Yano, Hiroshi; Katsube, Atsushi; Yano, Shingo; Masaki, Yasufumi; Tsunoda, Shinichiro; Sato, Shuzo; Migita, Kiyoshi; Kawakami, Atsushi

Chlamydia muridarum Infection Impacts Murine Models of Intestinal Inflammation and Cancer

鼠衣原体感染对小鼠肠道炎症和癌症模型的影响

Leung, Glory; Carrasco, Sebastian E; Mourino, Anthony J; Aydin, Mert; Mammone, Renata; Sonnenberg, Gregory F; Diehl, Gretchen; Artis, David; Yano, Hiroshi; Ricart Arbona, Rodolfo J; Lipman, Neil S